We have not yet seen a return to the level that was expected or that was historically experienced by the previous administrator. That said, we are achieving our target service levels now with the increased resourcing that we have brought on board over the last several months. One of the reasons we believe it has not returned to the level expected yet—although it will in the future—is that there are still some additional plan-design changes to come into force for the membership.
The major one of those still remaining would happen in January. We talked earlier about generic drugs. The utilization of generic-drug substitution will come into force for those who had brand-name drugs before July 1. We do anticipate that this will generate a significant number of calls, but we are increasing our resourcing to help support it.